Bifidobacterium infantis and Reduced Pulmonary Artery Hypertension

• A Randomized Controlled Trial of Probiotic Intervention for Reducing the Risk of Bronchopulmonary Dysplasia in Preterm Infants.

  • 2026-07
  • RCT · n = 244
  • Archives of medical research 57(5)
  • • Dandan Wang
    • Shanshan Wang
    • Huijie Wang
    • Xuan Zhang

  • PubMed: 41895129
  • DOI: 10.1016/j.arcmed.2026.103408

  6 Insights on

  • Reduced Pulmonary Artery Hypertension

  • High evidence
  • Large Human Trial
  • Clinical

  The intervention was also linked to a lower proportion of abnormal outcomes, including oxygen dependency at 12 months, pulmonary artery systolic pressure >30 mmHg, weight less than 2 standard deviations below the WHO standards at 12 months corrected age, and a Bayley-III score <70

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes